Option chain shows key data for Abivax's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Abivax.

Abivax (NASDAQ:ABVX) Stock, Option Chain

ABIVAX SA-ADR

Abivax

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Support from Other Analysts

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ABVX

BITF

COHR

EHTH

VEEV

This Veeva Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

xr:d:DAFfISjXLTA:2,j:2114733954,t:23040409

Movers

ABSI

AMCX

HUMA

INFN

Larimar Therapeutics, Inc. - Common Stock

LRMR

AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Abivax SA

Health Care

Press Releases

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax

Earnings

Abivax presents third quarter 2024 key financial information

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Management

Abivax Announces a Change to the Composition of its Board of Directors

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress

Abivax Publishes 2025 Financial Calendar

Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025

Abivax Announces Full Year 2024 Financial Results

Abivax publishes financial reports with the French and U.S. securities regulatory agencies

PARIS:ABVX

PARIS:FR

Akebia Therapeutics

Altimmune

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Celcuity

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Checkpoint Therapeutics, Inc. - Common Stock

Checkpoint Therapeutics

Erasca

Heron Therapeutics

Keros Therapeutics

MeiraGTx Hldgs

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Oruka Therapeutics

Precigen

PureTech Health plc - American Depositary Shares

PureTech Health

Regenxbio

Relay Therapeutics

Sage Therapeutics

Sana Biotechnology

Stoke Therapeutics

Tourmaline Bio

Tyra Biosciences

Upstream Bio

Verve Therapeutics

Morgan Stanley

Citizens Capital Markets

JMP Securities

Laidlaw & Co.

Comments

Abivax

Abivax (ABVX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga